News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Warns of Serious Risks Associated With Novo Nordisk A/S (NVO)'s Victoza



6/14/2011 8:37:51 AM

Novo Nordisk announced today the issuance of a letter to health care providers, as required by a Risk Evaluation and Mitigation Strategy, reminding them of important safety information associated with liraglutide injection. According to the FDA, a recent evaluation showed that some primary care providers are unaware of the serious risks associated with liraglutide (Victoza).

Read at News Release
Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES